These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 36833320

  • 1. Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool.
    Nakajima R, Zhao L, Zhou Y, Shirasawa M, Uchida A, Murakawa H, Fikriyanti M, Iwanaga R, Bradford AP, Araki K, Warita T, Ohtani K.
    Genes (Basel); 2023 Feb 02; 14(2):. PubMed ID: 36833320
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification of novel target genes specifically activated by deregulated E2F in human normal fibroblasts.
    Kitamura H, Ozono E, Iwanaga R, Bradford AP, Okuno J, Shimizu E, Kurayoshi K, Kugawa K, Toh H, Ohtani K.
    Genes Cells; 2015 Sep 02; 20(9):739-57. PubMed ID: 26201719
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tumor suppressor TAp73 gene specifically responds to deregulated E2F activity in human normal fibroblasts.
    Ozono E, Komori H, Iwanaga R, Tanaka T, Sakae T, Kitamura H, Yamaoka S, Ohtani K.
    Genes Cells; 2012 Aug 02; 17(8):660-72. PubMed ID: 22702391
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The phosphatidyl inositol 3 kinase pathway does not suppress activation of the ARF and BIM genes by deregulated E2F1 activity.
    Kurayoshi K, Okuno J, Ozono E, Iwanaga R, Bradford AP, Kugawa K, Araki K, Ohtani K.
    Biochem Biophys Res Commun; 2017 Jan 22; 482(4):784-790. PubMed ID: 27888102
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Apaf-1 is a transcriptional target for E2F and p53.
    Moroni MC, Hickman ES, Lazzerini Denchi E, Caprara G, Colli E, Cecconi F, Müller H, Helin K.
    Nat Cell Biol; 2001 Jun 22; 3(6):552-8. PubMed ID: 11389439
    [Abstract] [Full Text] [Related]

  • 12. Balancing proliferation and apoptosis in vivo: the Goldilocks theory of E2F/DP action.
    Yamasaki L.
    Biochim Biophys Acta; 1999 Mar 25; 1423(2):M9-15. PubMed ID: 10214348
    [Abstract] [Full Text] [Related]

  • 13. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.
    Oncogene; 2006 Jan 12; 25(2):230-9. PubMed ID: 16158053
    [Abstract] [Full Text] [Related]

  • 14. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
    Kitagawa M, Aonuma M, Lee SH, Fukutake S, McCormick F.
    Oncogene; 2008 Sep 11; 27(40):5303-14. PubMed ID: 18521084
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
    Ofir M, Hacohen D, Ginsberg D.
    Mol Cancer Res; 2011 Apr 11; 9(4):440-7. PubMed ID: 21454377
    [Abstract] [Full Text] [Related]

  • 18. JNK activation is regulated by E2F and promotes E2F1-induced apoptosis.
    Bashari D, Hacohen D, Ginsberg D.
    Cell Signal; 2011 Jan 11; 23(1):65-70. PubMed ID: 20800677
    [Abstract] [Full Text] [Related]

  • 19. Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas.
    Gorgoulis VG, Zacharatos P, Mariatos G, Kotsinas A, Bouda M, Kletsas D, Asimacopoulos PJ, Agnantis N, Kittas C, Papavassiliou AG.
    J Pathol; 2002 Oct 11; 198(2):142-56. PubMed ID: 12237873
    [Abstract] [Full Text] [Related]

  • 20. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
    Aslanian A, Iaquinta PJ, Verona R, Lees JA.
    Genes Dev; 2004 Jun 15; 18(12):1413-22. PubMed ID: 15175242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.